Biotech
New Hope for Eye Disease from Merck
Merck's new eye medicine shows great promise in helping people with a serious eye disease keep their sight.
Merck, a big drug company, brings good news for those with diabetic macular edema, or DME. This eye disease can take away eyesight. Many people with diabetes face this problem.
Merck bought a special medicine for $3 billion. This medicine is called Brunello. It helps stop vision loss from DME. Recent tests for Brunello went very well. The medicine met its main goal. It worked just as Merck hoped.
This success means Brunello can move closer to helping patients. It offers new hope for millions who live with DME. Protecting vision is very important. Merck's work could change many lives for the better.
Source: FierceBiotech
#Biotech#Merck#Eye Disease#Diabetes
More from Biotech
